Under the terms of the transaction, Ortho-McNeil will obtain a one-year exclusive option to selected adenosine receptor antagonists discovered by Adenosine Therapeutics. In connection with this, Johnson &
Paclitaxel, marketed as Taxol by Bristol-Myers Squibb, is a first-line treatment for recurrent head and neck squamous cell carcinoma (HNSCC). Panzem (2-methoxyestradiol or 2ME2), EntreMed’s lead drug candidate,
The trial has been initiated by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The vaccine candidate was jointly
The trial was a multi-center double-blind, randomized, placebo-controlled parallel group study. Patients in the study had advanced cancer and were experiencing pain that was not responding adequately to
Although the board of Oxford BioMedica confirmed that the discussions were taking place in a recent statement, it also stressed that these discussions are at an early stage
“Lipin regulates how the body stores and burns fat. Our findings suggest that differences in lipin levels may play a role in why some people are more prone
The two companies have announced a collaborative agreement whereby the clinical facilities, trial site networks, proprietary technologies and scientific expertise of each company would be made available to
The study of the dipeptidyl peptidase-IV (DP-IV) inhibitor, PSN9301, will enroll approximately 60 patients into a two-week in-house dosing and monitoring protocol which will be conducted in Berlin,
Alagebrium has demonstrated an ability to reverse erectile dysfunction (ED) in a preclinical model of ED in diabetic rats, through what appears to be a unique mechanism of
Xyrem (sodium oxybate) is currently marketed as the first and only approved treatment for cataplexy, a sudden loss of muscle tone that is a debilitating symptom of narcolepsy.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.